[{"id":"363e96eb-5e3f-442c-b58a-38eaeb74e6d4","acronym":"","url":"https://clinicaltrials.gov/study/NCT04684563","created_at":"2021-03-16T19:53:11.570Z","updated_at":"2024-07-02T16:35:04.117Z","phase":"Phase 1","brief_title":"huCART19-IL18 in NHL/CLL Patients","source_id_and_acronym":"NCT04684563","lead_sponsor":"University of Pennsylvania","biomarkers":" ALK • BCL2 • CD19 • BCL6","pipe":" | ","alterations":" CD19 expression • BCL6 rearrangement • BCL2 rearrangement","tags":["ALK • BCL2 • CD19 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • BCL6 rearrangement • BCL2 rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e huCART19 • huCART19-IL18"],"overall_status":"Recruiting","enrollment":" Enrollment 72","initiation":"Initiation: 05/06/2021","start_date":" 05/06/2021","primary_txt":" Primary completion: 05/01/2036","primary_completion_date":" 05/01/2036","study_txt":" Completion: 05/01/2036","study_completion_date":" 05/01/2036","last_update_posted":"2024-05-13"},{"id":"0b6b368a-64de-411b-8b60-f0b6a6b8703e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05989204","created_at":"2023-08-14T15:10:30.724Z","updated_at":"2024-07-02T16:35:12.090Z","phase":"Phase 1","brief_title":"TmCD19-IL18 in CD19+ Cancers","source_id_and_acronym":"NCT05989204","lead_sponsor":"University of Pennsylvania","biomarkers":" ALK • BCL2 • CD19 • BCL6","pipe":" | ","alterations":" CD19 expression • BCL6 rearrangement • BCL2 rearrangement","tags":["ALK • BCL2 • CD19 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • BCL6 rearrangement • BCL2 rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e huCART19-IL18"],"overall_status":"Recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 11/13/2023","start_date":" 11/13/2023","primary_txt":" Primary completion: 10/01/2026","primary_completion_date":" 10/01/2026","study_txt":" Completion: 10/01/2041","study_completion_date":" 10/01/2041","last_update_posted":"2024-04-01"}]